AK135

· Akeso Biopharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AK135, covering 2025-03-06 to 2025-03-06. Get the full timeline:

Most recent: Clinical Trial Update: AK135 in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN) [Phase 1]